Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
SD1-H5143 | Human | Human SDF-1 / CXCL12 Protein, His Tag |
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Olaptesed Pegol | NOX-A12 | Phase 2 Clinical | Noxxon Pharma | Hematopoietic stem cell transplantation (HSCT); Glioblastoma; Pancreatic Neoplasms; Multiple Myeloma; Colorectal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | Details |
Emilimogene sigulactibac | ILP100h | Phase 2 Clinical | Ilya Pharma AB | Diabetic Foot; Wounds and Injuries | Details |
JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Surgical Wound; Peripheral Arterial Disease | Details |
CK-0804 | CK-0804 | Phase 1 Clinical | Cellenkos Inc | Primary Myelofibrosis | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
MyoCell SDF-1 | MyoCell SDF-1 | Clinical | U.S. Stem Cell | Heart Failure | Details |
Olaptesed Pegol | NOX-A12 | Phase 2 Clinical | Noxxon Pharma | Hematopoietic stem cell transplantation (HSCT); Glioblastoma; Pancreatic Neoplasms; Multiple Myeloma; Colorectal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | Details |
Emilimogene sigulactibac | ILP100h | Phase 2 Clinical | Ilya Pharma AB | Diabetic Foot; Wounds and Injuries | Details |
JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Surgical Wound; Peripheral Arterial Disease | Details |
CK-0804 | CK-0804 | Phase 1 Clinical | Cellenkos Inc | Primary Myelofibrosis | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
MyoCell SDF-1 | MyoCell SDF-1 | Clinical | U.S. Stem Cell | Heart Failure | Details |
This web search service is supported by Google Inc.